Shares of Grail, Inc. (NASDAQ:GRAL - Get Free Report) traded up 8.2% on Thursday . The stock traded as high as $28.92 and last traded at $28.84. 248,290 shares were traded during mid-day trading, a decline of 75% from the average session volume of 993,628 shares. The stock had previously closed at $26.67.
Wall Street Analyst Weigh In
GRAL has been the topic of a number of recent research reports. Wolfe Research initiated coverage on shares of Grail in a research report on Friday, November 15th. They set a "peer perform" rating on the stock. Guggenheim initiated coverage on Grail in a research note on Thursday, October 17th. They issued a "neutral" rating for the company. Finally, Morgan Stanley began coverage on Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price target for the company.
Get Our Latest Research Report on Grail
Grail Stock Up 20.9 %
The company has a 50 day simple moving average of $20.78 and a two-hundred day simple moving average of $16.81.
Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The company had revenue of $28.65 million during the quarter. On average, equities analysts anticipate that Grail, Inc. will post -65.16 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Grail news, CFO Aaron Freidin sold 30,452 shares of the business's stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the transaction, the chief financial officer now owns 268,277 shares of the company's stock, valued at approximately $3,761,243.54. The trade was a 10.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Institutional Investors Weigh In On Grail
Several institutional investors and hedge funds have recently modified their holdings of the company. FNY Investment Advisers LLC acquired a new stake in Grail during the 4th quarter worth approximately $26,000. New York State Common Retirement Fund purchased a new position in Grail during the fourth quarter worth $59,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Grail during the fourth quarter worth $64,000. Manchester Capital Management LLC acquired a new position in Grail in the fourth quarter valued at $123,000. Finally, China Universal Asset Management Co. Ltd. purchased a new position in Grail in the fourth quarter valued at about $127,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Read More
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
